Eleven studies (two prospective, one retrospective, and eight case reports) [28,30,32,33,36,44,46,47,50,52,53] have compared the diagnostic performances of FAP-specific radiopharmaceuticals against other tracers in patients with various neoplasms. Here, FAP is linked to neoplasm.